Moving the needle forward

NEWS > Moving the needle forward 29 March 2023 Moving the needle forward HOW PMT COORDINATORS ARE HELPING ACCELERATE CANCER RESEARCH In May 2016, Lee-Anne Pickard, a nurse with close to 20 years of experience in cancer research, was sent an article from the...

Exactis, in top clinical trial companies based in Canada

We are pleased to have been chosen among the 39 best clinical trial companies in Canada according to the site: https://beststartup.ca/ Here is a summary of the article: This article showcases our top picks for the best Canada based Clinical Trials companies. These...

Exactis’ is pleased to announce their latest publication in Clinical and Translational Medicine entitled “Copy number and transcriptome alterations associated with metastatic lesion response to treatment in colorectal cancer”.

Since their initial description in 19481, small DNA fragments travelling in the non-cellular component of internal bodily fluids and excretions have revolutionized numerous fields in public health and preventive medicine2,3,4,5,6. Although its origins have been a...
The Next Steps for Precision Oncology in Canada

The Next Steps for Precision Oncology in Canada

Exactis Innovation is a pan-Canadian research network that accelerates biomarker-led clinical and translational research in areas of high-unmet medical need. Precision Medicine in Cancer Care The past decade has seen the emergence of precision medicine, a complicated...